Under-eye patches are one of the fastest-growing peptide formats, and "peptide eye patches" now covers two quite different objects. This page separates them and counts what each has been tested for. The answer changes what a peptide claim on the box can mean. It reviews formats and published trials; it does not rank or recommend any product.
Two products, one name
| Hydrogel patch | Dissolving microneedle patch | |
|---|---|---|
| What it is | A soft, cool sheet of water-rich gel, often crescent-shaped | A small patch covered in hundreds of tiny points made of hyaluronic acid or a similar material |
| How ingredients reach skin | Released onto the surface; must cross the skin barrier unaided | The points pierce the outer layer and dissolve inside it, carrying their contents below the surface |
| What most packs sell | Hydration, de-puffing, "brightening", peptide and collagen claims | Wrinkle reduction around the eyes and nasolabial folds |
| Published wrinkle trials we found | None | 23 records, several controlled |
The distinction matters because the outer layer of skin is the main obstacle for peptides, most of which are large molecules; see what peptides do for skin for how little of that crossing has been measured. A microneedle patch is built to get past that layer. A gel sheet is not.
The literature, counted
On 28 September 2026, a search of Europe PMC's copy of MEDLINE for eye, hydrogel or microneedle patches together with wrinkles, crow's feet, periorbital skin or dark circles returned 27 records. We read every title and abstract:
- 23 concern microneedle patches.
- 0 tested a hydrogel sheet patch on wrinkles or under-eye skin.
- 4 were off topic (neonatal lupus, newborn eye protection, cold packs after nose surgery).
The absence is not proof that gel patches do nothing. It means the kind of patch most often sold as a peptide eye patch has not been put through a published wrinkle trial that we could find, and any effect claimed for one rests on the brand's own testing.
The one trial that isolated a peptide
Only one study we found compared the same patch with and without a peptide. In An and colleagues' double-blind, randomized, split-face trial (Annals of Dermatology 2019, PMID 33911590; funded by the Korea Health Industry Development Institute), 52 Korean women were divided into three groups: a cross-linked hyaluronic-acid microneedle patch alone, the same patch carrying acetyl hexapeptide-8 (Argireline), or the same patch carrying epidermal growth factor. Patches were applied to the eye area and the nasolabial folds for four hours, once a week, so the microneedles dissolved completely, for 29 days.
- Fifty women (96.2%) completed the study, with no serious adverse effects.
- All three groups improved on wrinkles and hydration (p < 0.01).
- The peptide patch and the growth-factor patch both improved wrinkles significantly more than the plain patch (p < 0.05).
- Around the eyes, the paper reports fine-wrinkle improvement of 12.5%, 13.6% and 14.6% on days 1, 3 and 5 after the first peptide patch, against 9.4%, 8.7% and 5.9% for the plain patch, whose effect faded over the same days.
That is the best evidence in this format for a peptide adding something. It is one trial, of 29 days, with a patch that pierces the skin and stays on for hours. It says nothing directly about a gel sheet worn for twenty minutes.
The format itself changes the result
A second trial shows why the patch type matters as much as the ingredient. Choi and colleagues gave 34 Korean women a hyaluronic-acid microneedle patch on one side of the face and an essence containing the same active ingredients on the other, twice a week for eight weeks (Dermatologic Therapy 2017, PMID 28892233). Wrinkles and elasticity improved on both sides, but more on the patch side at week 8; the assessments included skin-replica measurement and two blinded dermatologists. No irritation was found.
Other controlled microneedle trials point the same way with non-peptide actives. A double-blind study of 23 people found a vitamin C-loaded microneedle patch improved crow's feet against a control (Lee 2016, PMID 26648582), and a split-phase trial of 82 people used a patch of 650 dissolving microneedles carrying hyaluronic and ferulic acids, applied for 25 minutes twice a week for six weeks (Zvezdin 2020, PMID 32485024). The patch in the one palmitoyl tripeptide-5 study was also a microneedle patch, containing five actives with no peptide-free comparison (Avcil 2020, PMID 31134751; see our palmitoyl tripeptide-5 file).
What is inside a typical peptide eye patch
Our ingredient analysis of one widely sold hydrogel patch, COSRX's Peptide Collagen Hydrogel Eye Patch, found its four named peptides at positions 31, 33, 34 and 39 of 41, below niacinamide at 4, adenosine at 19 and caffeine at 22. One of the four "peptides" was a 99,369-dalton recombinant collagen, and the peptide sold for puffiness, acetyl tetrapeptide-5, has a single cell-culture paper and no human study of its own. That pattern — a patch named for its peptides whose peptides sit at the bottom of the list — is worth checking on any box, and it repeats in full-face gel sheets such as the Medicube PDRN gel mask, whose thirteen peptide ingredients occupy its last thirteen positions. As our peptide serum page explains, a peptide's position below the 1% line says nothing about its amount.
Reading a peptide eye patch
- Check which kind it is. "Microneedle", "micro-dart" or "dissolving needles" describes the format the trials tested. A gel or hydrogel sheet is a different product.
- Look at what sits above the peptides. Caffeine, niacinamide and adenosine have larger published files than most cosmetic peptides, and on many patches they are the higher-listed actives.
- Treat trial wear times as study protocols, not instructions. Four hours weekly in the peptide trial and 25 minutes twice weekly in another are what those papers did; a product's label states its own directions.
- Puffiness is a separate claim. Most wrinkle trials did not measure it, and our peptide eye cream page covers what has been tested for bags and dark circles.
Sources
- An JH, Lee HJ, Yoon MS, Kim DH. Anti-Wrinkle Efficacy of Cross-Linked Hyaluronic Acid-Based Microneedle Patch with Acetyl Hexapeptide-8 and Epidermal Growth Factor on Korean Skin. Ann Dermatol 2019. PMID 33911590 (full text read).
- Choi SY, et al. Hyaluronic acid microneedle patch for the improvement of crow's feet wrinkles. Dermatol Ther 2017. PMID 28892233.
- Lee C, et al. Evaluation of the anti-wrinkle effect of an ascorbic acid-loaded dissolving microneedle patch via a double-blind, placebo-controlled clinical study. Int J Cosmet Sci 2016. PMID 26648582.
- Zvezdin V, et al. Microneedle patch based on dissolving, detachable microneedle technology for improved skin quality of the periorbital region. Part 2: Clinical Evaluation. Int J Cosmet Sci 2020. PMID 32485024.
- Avcil M, et al. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches. J Cosmet Dermatol 2020. PMID 31134751.
- Europe PMC (MEDLINE subset) title and abstract search for patch formats and periorbital or wrinkle terms, 28 September 2026; all 27 records classified by hand.
- COSRX ingredient positions as recorded on our analysis page (brand list read 18 September 2026).